Improvement of fibrosis is associated with the decrease of collagen III formation biomarker Pro-C3 in patients with non-alcoholic steatohepatitis

被引：0
|
作者：
Luo, Yi [1 ]
Vincent, Robert [2 ]
Gagnon, Robert C. [1 ]
Charles, Edgar D. [1 ]
Oseini, Abdul [2 ]
Mirshahi, Faridoddin [2 ]
Banini, Bubu A. [2 ]
Daita, Kalyani [2 ]
Idowu, Michael O. [2 ]
Rosen, Glenn D. [1 ]
Jarai, Gabor [1 ]
Christian, Rose [1 ]
Sanyal, Arun J. [2 ]
机构：
[1] Bristol Myers Squibb, Lawrenceville, NJ USA
[2] Virginia Commonwealth Univ, Richmond, VA USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
633
引用
收藏
页码：345A / 345A
页数：1
相关论文
共 50 条
  • [41] Factors associated with the presence of non-alcoholic steatohepatitis (NASH) lesions in patients with hepatitis C
    Solis-Herruzo, JA
    Perez-Carreras, M
    Garfia, C
    Fernandez-Vazquez, I
    Bernardos, E
    Rivas, E
    Colina, F
    JOURNAL OF HEPATOLOGY, 2004, 40 : 176 - 176
  • [42] Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis
    Chalasani, Naga
    Abdelmalek, Manal F.
    Loomba, Rohit
    Kowdley, Kris, V
    McCullough, Arthur J.
    Dasarathy, Srinivasan
    Neuschwander-Tetri, Brent A.
    Terrault, Norah
    Ferguson, Beatrice
    Shringarpure, Reshma
    Shapiro, David
    Sanyal, Arun J.
    LIVER INTERNATIONAL, 2019, 39 (05) : 924 - 932
  • [43] Improvements of Hepatic Fibrosis and Hepatic Collagen Deposition in Non-Alcoholic Steatohepatitis (NASH) Treated with Selonsertib are Associated with Improvement of Patient-Reported Outcomes (PROs)
    Younossi, Zobair M.
    Stepanova, Maria
    Goodman, Zachary D.
    Lawitz, Eric
    Charlton, Michael R.
    Loomba, Rohit
    Myers, Robert P.
    Subramanian, Mani
    McHutchison, John G.
    Hunt, Sharon
    HEPATOLOGY, 2017, 66 : 1170A - 1171A
  • [44] Analyze of Ballooning Biomarker in Patients with Non-Alcoholic Steatohepatitis: A Multicentre Prospective Study
    Ogawa, Yuji
    Honda, Yasushi
    Kessoku, Takaomi
    Imajo, Kento
    Yoneda, Msato
    Andou, Tatsuya
    Kamiguchi, Hidenori
    Amano, Yuichiro
    Ogawa, Shinji
    Nakahara, Takashi
    Takahashi, Hirokazu
    Hyogo, Hideyuki
    Saito, Satoru
    Chayama, Kazuaki
    Eguchi, Yuichiro
    Nakajima, Atsushi
    HEPATOLOGY, 2018, 68 : 984A - 985A
  • [45] Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    Tasneem, Abbas Ali
    Luck, Nasir Hassan
    Majid, Zain
    TROPICAL DOCTOR, 2018, 48 (02) : 107 - 112
  • [46] SERUM DES-ACYLGHRELIN CONCENTRATION IS ASSOCIATED WITH HISTOLOGIC NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Estep, M.
    Vernon, G.
    Wang, L.
    Stepanova, M.
    Younoszai, A.
    Elariny, H.
    Goodman, Z.
    Chandhoke, V.
    Baranova, A.
    Younossi, Z.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S350 - S351
  • [47] Fibrosis Biomarkers CA15-3 and Thrombospondin-2 are Associated with Higher Hepatic Collagen Content in Non-alcoholic Steatohepatitis (NASH)-related Fibrosis
    Felix, Sean
    Estep, James M.
    Birerdinc, Aybike
    Monge, Fanny
    Alaparthi, Lakshmi
    Stepanova, Maria
    Lam, Brian
    Rajput, Bijal
    Golabi, Pegah
    Jeffers, Thomas
    Hellings, Samuel
    Brown, Elizabeth
    Spires, Thomas
    Yarde, Melissa
    Luo, Yi
    Sanfiz, Anthony
    Thompson, John
    Cvijic, Mary Ellen
    Charles, Edgar
    Zhao, Lei
    Gordon, David
    Karrar, Azza
    Tan, Albert
    Abdelaal, Hala
    Nader, Fatema
    Goodman, Zachary
    Younossi, Zobair
    JOURNAL OF HEPATOLOGY, 2021, 75 : S395 - S396
  • [48] Novel genetic markers associated with risk of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver diseases
    Huang, HJ
    Merriman, RB
    Chokkalingam, AP
    Tuason, O
    Schrodi, SJ
    Aouizerat, BE
    Chan, J
    Catanese, JJ
    Leong, DU
    McAllister, LB
    Sninsky, JJ
    Bass, NN
    GASTROENTEROLOGY, 2005, 128 (04) : A694 - A695
  • [49] Costs associated with non-alcoholic steatohepatitis disease progression in medicare patients
    Fishman, Jesse
    Kim, Yestle
    Medicis, Joe
    Davis, Matthew
    Nunag, Dominic
    Gish, Robert G.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S494 - S494
  • [50] The neo-epitope specific PRO-C3 ELISA measures true formation of type III collagen associated with liver and muscle parameters
    Nielsen, Mette J.
    Nedergaard, Anders F.
    Sun, Shu
    Veidal, Sanne S.
    Larsen, Lise
    Zheng, Qinlong
    Suetta, Charlotte
    Henriksen, Kim
    Christiansen, Claus
    Karsdal, Morten A.
    Leeming, Diana J.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2013, 5 (03): : 303 - 315
12345